Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · IEX Real-Time Price · USD
4.090
-0.030 (-0.73%)
May 21, 2024, 4:00 PM EDT - Market closed

Prelude Therapeutics Market Cap

Prelude Therapeutics has a market cap or net worth of $224.66 million as of May 21, 2024. Its market cap has decreased by -29.44% in one year.

Market Cap
224.66M
Enterprise Value
36.33M
1-Year Change
-29.44%
Ranking
Category
Stock Price
$4.09

Market Cap Chart

Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $224.66M, a decrease of -72.15%. That is a compound annual growth rate of -29.51%.

History

DateMarket Cap% Change
May 21, 2024224.70M-0.71%
May 20, 2024226.30M3.00%
May 17, 2024219.70M-6.55%
May 16, 2024235.10M7.01%
May 15, 2024219.70M3.63%
May 14, 2024212.00M1.58%
May 13, 2024208.70M1.85%
May 10, 2024204.90M-8.36%
May 9, 2024223.60M13.39%
May 8, 2024197.20M-2.95%
May 7, 2024203.20M-3.38%
May 6, 2024210.30M-0.80%
May 3, 2024212.00M-3.24%
May 2, 2024219.10M6.93%
May 1, 2024204.90M-1.06%
Apr 30, 2024207.10M-1.80%
Apr 29, 2024210.90M-5.64%
Apr 26, 2024223.50M0.72%
Apr 25, 2024221.90M4.42%
Apr 24, 2024212.50M-
Apr 23, 2024212.50M0.52%
Apr 22, 2024211.40M3.48%
Apr 19, 2024204.30M8.15%
Apr 18, 2024188.90M-17.73%
Apr 17, 2024229.60M-14.87%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AngioDynamics 232.72M
EDAP TMS 231.16M
Acumen Pharmaceuticals 230.71M
Innate Pharma 230.40M
NeuroPace 229.57M
2seventy bio 225.16M
Agenus 224.69M
Delcath Systems 223.12M
Market Cap Rankings